[HTML][HTML] Novel agents for the pharmacological treatment of alcohol use disorder

EM Burnette, SJ Nieto, EN Grodin, LR Meredith… - Drugs, 2022 - Springer
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with
only three widely-approved pharmacotherapies. Given that AUD is a very heterogeneous …

[HTML][HTML] Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis

L Tretter, A Patocs, C Chinopoulos - Biochimica et Biophysica Acta (BBA) …, 2016 - Elsevier
Succinate is an important metabolite at the cross-road of several metabolic pathways, also
involved in the formation and elimination of reactive oxygen species. However, it is …

Alcohol withdrawal syndrome: mechanisms, manifestations, and management

S Jesse, G Bråthen, M Ferrara, M Keindl… - Acta Neurologica …, 2017 - Wiley Online Library
The alcohol withdrawal syndrome is a well‐known condition occurring after intentional or
unintentional abrupt cessation of heavy/constant drinking in patients suffering from alcohol …

Identification and management of alcohol withdrawal syndrome

A Mirijello, C D'Angelo, A Ferrulli, G Vassallo… - Drugs, 2015 - Springer
Symptoms of alcohol withdrawal syndrome (AWS) may develop within 6–24 h after the
abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from …

Treatment of alcohol use disorders in patients with alcoholic liver disease

G Addolorato, A Mirijello, P Barrio, A Gual - Journal of hepatology, 2016 - Elsevier
Alcohol use disorders (AUDs) is one of the leading causes of disease and disability in
almost all European countries. Among the alcohol-related diseases, alcoholic liver disease …

Benzodiazepines for alcohol withdrawal

L Amato, S Minozzi, S Vecchi… - Cochrane Database of …, 2010 - cochranelibrary.com
Background Alcohol abuse and dependence represents a serious health problem
worldwide with social, interpersonal and legal interpolations. Benzodiazepines have been …

Breaking the loop: oxytocin as a potential treatment for drug addiction

IS McGregor, MT Bowen - Hormones and behavior, 2012 - Elsevier
Drug use typically occurs within a social context, and social factors play an important role in
the initiation, maintenance and recovery from addictions. There is now accumulating …

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity …

AR Lingford-Hughes, S Welch… - Journal of …, 2012 - journals.sagepub.com
The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Mechanisms of action and persistent neuroplasticity by drugs of abuse

ER Korpi, B den Hollander, U Farooq… - Pharmacological …, 2015 - Elsevier
Adaptation of the nervous system to different chemical and physiologic conditions is
important for the homeostasis of brain processes and for learning and remembering …

Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome

L Amato, S Minozzi, M Davoli - Cochrane database of …, 2011 - cochranelibrary.com
Background Alcohol abuse and dependence represents a very serious health problem
worldwide with major social, interpersonal and legal interpolations. Pharmacological …